CN103893342A - Traditional Chinese medicine oral liquid for preventing and treating toxoplasmosis, and preparation method and application thereof - Google Patents
Traditional Chinese medicine oral liquid for preventing and treating toxoplasmosis, and preparation method and application thereof Download PDFInfo
- Publication number
- CN103893342A CN103893342A CN201210578391.6A CN201210578391A CN103893342A CN 103893342 A CN103893342 A CN 103893342A CN 201210578391 A CN201210578391 A CN 201210578391A CN 103893342 A CN103893342 A CN 103893342A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- oral liquid
- toxoplasmosis
- preventing
- medicine oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine oral liquid for preventing and treating toxoplasmosis. The traditional Chinese medicine oral liquid is for oral administration, includes five Chinese herbal medicines consisting of lightyellow sophora root, amur cork-tree bark, giant knotweed rhizome, raw hawthorn fruit and officinal magnolia bark and can be used for treating people and animals with toxoplasmosis; the five Chinese herbal medicines can be directly used after decoction with water and can also be used for preparation of internal medicines like an oral liquid and a tablet for clinical usage. A medicament prepared from the five Chinese herbal medicines has a good effect and a cheap price.
Description
Technical field
The present invention relates to field of medicaments, more particularly, relate to a kind of Chinese medicine oral liquid of preventing and treating toxoplasmosis.
Background technology
Toxoplasma is cytozoon (a kind of zoonosis), in human body cell, exist with cyst and two kinds of forms of trophozoite (adult), trophozoite is bitten nutrient breeding rapidly at cell endocytic, destroys the normal function of human tissue organ, reduces the inherent immunity power of human body self.Patient is at the ill initial stage without obvious symptom, and immunity is low to a certain extent in the time of the outbreak of other disease, and toxoplasmosis is covered by other disease again, causes the delay of the state of an illness.
Conventional therapy is generally to adopt oral import spiramycin at present, 49 days courses for the treatment of, middle drug withdrawal 7 days, the untoward reaction causing to reduce side effect, also useful oral sulfa drugs, these medicines have larger side effect, moreover also all can only suppress the breeding of trophozoite, and can not kill trophozoite.
Once toxoplasma morbidity, will be very large to the injury of body, particularly to women, can cause miscarriage or infertile.Even cure after toxoplasma morbidity, also can leave certain sequela, therefore prevention seems especially important.
The object of this invention is to provide a kind of medicine that prevents toxoplasmosis, again human body is not occurred to poison and side effect to reach prevention toxoplasmosis, simultaneously it is also toxoplasma potentiation or replace medicine when other medicines are developed immunity to drugs.
Radix Sophorae Flavescentis heat clearing and damp drying, parasite killing, diuresis; Cortex Phellodendri heat clearing and damp drying, eliminating fire and detoxication, except hectic fever due to YIN-deficiency clearind deficient heat.Rhizoma Polygoni Cuspidati has heat-clearing and toxic substances removing, refrigerant solution administration, stomach invigorating food effect clearly.Fructus Crataegi has effect of spleen invigorating, sedan-chair taste, digestion promoting; Cortex Magnoliae Officinalis has effect of removing dampness by means of aromatics.Five medicine 5 use have reached prevention Toxoplasma gondii and have infected, and improve effect of Abwehrkraft des Koepers.
Through clinical verification, fine to toxoplasmosis effect behind five recurrence due to taking drug sides, the domestic prescription there is not yet taking five kinds of Chinese medicine as principal agent at present.
Summary of the invention
The invention provides a kind of prescriptions of Chinese medicine, it is characterized by and comprise Radix Sophorae Flavescentis, Cortex Phellodendri, Rhizoma Polygoni Cuspidati, Fructus Crataegi, Cortex Magnoliae Officinalis five tastes principal agent, can be for the toxoplasmosis of humans and animals.
A kind of Chinese medicine composition that prevents toxoplasmosis of the present invention, is characterized by taking Radix Sophorae Flavescentis, Cortex Phellodendri, Rhizoma Polygoni Cuspidati, Fructus Crataegi, Cortex Magnoliae Officinalis five kinds of Chinese medicine as principal agent, adds some excipient, can make oral liquid, tablet.
A kind of Chinese medicine composition that prevents toxoplasmosis of the present invention, is characterized in that it is made by following weight proportion: Radix Sophorae Flavescentis 2-10, Cortex Phellodendri 4-8, Rhizoma Polygoni Cuspidati 1-5, Fructus Crataegi 5-15, Cortex Magnoliae Officinalis 2-10.
A kind of Chinese medicine composition that prevents toxoplasmosis of the present invention, for oral administration after can directly five kinds of Chinese medicine water being decocted, also can make extract, make other dosage form.
A kind of Chinese medicine composition that prevents toxoplasmosis of the present invention, it is characterized by excipient can be water, correctives, antiseptic, stabilizing agent.
Toxoplasmosis effect to humans and animals after five tastes medicament composing prescription is fine, and easy to use, five kinds of Chinese medicine wide material sources, and low price, is applicable to industrialization and produces.
Specific embodiment
Get Radix Sophorae Flavescentis 8g, Cortex Phellodendri 4g, Rhizoma Polygoni Cuspidati 4g, Fructus Crataegi 10g, the Cortex Magnoliae Officinalis 2g 1000ml that adds water, decoct, for oral administration, every day twice, take one day for every dose, can prevent the toxoplasmosis of humans and animals to infect.
Claims (5)
1. prevent and treat a Chinese medicine oral liquid for toxoplasmosis, it is characterized by and comprise Radix Sophorae Flavescentis, Cortex Phellodendri, Rhizoma Polygoni Cuspidati, Fructus Crataegi, Cortex Magnoliae Officinalis five tastes principal agent, can be for the toxoplasmosis of humans and animals.
2. a kind of Chinese medicine oral liquid of preventing and treating toxoplasmosis according to claim 1, is characterized by taking Radix Sophorae Flavescentis, Cortex Phellodendri, Rhizoma Polygoni Cuspidati, Fructus Crataegi, Cortex Magnoliae Officinalis five kinds of Chinese medicine as principal agent, adds some excipient, can make oral liquid, tablet.
3. a kind of Chinese medicine oral liquid of preventing and treating toxoplasmosis according to claim 1, is characterized in that it is made by following weight proportion: Radix Sophorae Flavescentis 2-10, Cortex Phellodendri 4-8, Rhizoma Polygoni Cuspidati 1-5, Fructus Crataegi 5-15, Cortex Magnoliae Officinalis 2-10.
4. a kind of Chinese medicine oral liquid of preventing and treating toxoplasmosis according to claim 1, for oral administration after can directly five kinds of Chinese medicine water being decocted, also can make extract, make other dosage form.
5. a kind of Chinese medicine oral liquid of preventing and treating toxoplasmosis according to claim 2, it is characterized by excipient can be water, correctives, antiseptic, stabilizing agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210578391.6A CN103893342A (en) | 2012-12-28 | 2012-12-28 | Traditional Chinese medicine oral liquid for preventing and treating toxoplasmosis, and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210578391.6A CN103893342A (en) | 2012-12-28 | 2012-12-28 | Traditional Chinese medicine oral liquid for preventing and treating toxoplasmosis, and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103893342A true CN103893342A (en) | 2014-07-02 |
Family
ID=50985128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210578391.6A Pending CN103893342A (en) | 2012-12-28 | 2012-12-28 | Traditional Chinese medicine oral liquid for preventing and treating toxoplasmosis, and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103893342A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116076702A (en) * | 2022-08-31 | 2023-05-09 | 李勇忠 | Insect repellent formula and processing technology thereof |
-
2012
- 2012-12-28 CN CN201210578391.6A patent/CN103893342A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116076702A (en) * | 2022-08-31 | 2023-05-09 | 李勇忠 | Insect repellent formula and processing technology thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102526318A (en) | Chinese medicinal composition for preventing and treating chicken diseases and preparation method thereof | |
| CN101468195A (en) | 'Anweikang' Chinese medicine preparation | |
| CN101926882A (en) | Medicinal composition for treating cancer and preparation methods thereof | |
| CN103083500A (en) | Chinese medicinal composition treating toxoplasmosis | |
| CN107137517A (en) | Eliminate autonomic drug and pharmaceutical composition of Pain Treatment cancer and preparation method thereof | |
| CN103083446A (en) | Chinese medicinal composition for prevention of toxoplasmosis | |
| CN104758529A (en) | Traditional Chinese medicine composition for treating common cold due to wind-cold | |
| CN101890117B (en) | Traditional Chinese medicinal composition for treating acnes | |
| CN103893342A (en) | Traditional Chinese medicine oral liquid for preventing and treating toxoplasmosis, and preparation method and application thereof | |
| CN103212003A (en) | Medicine and food capable of treating hot and damp diarrhea | |
| CN103463527B (en) | Traditional Chinese medicine composition for treating rubella | |
| CN101700373B (en) | Traditional Chinese medicine used for smoking cessation | |
| CN104888132A (en) | Traditional Chinese medicine composition for treatment of chronic gastritis | |
| CN104225376A (en) | Traditional Chinese medicinal composition for treating pernicious vomiting due to liver-stomach disharmony and application thereof | |
| CN103736027A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN102274418A (en) | Medicinal powder for preventing and treating anemofrigid cold of livestock and poultry | |
| CN103566005A (en) | Traditional Chinese medicine for treating poultry virus diseases and preparation method thereof | |
| CN102743508B (en) | Compound propolis composition for treating avian infectious laryngotracheitis and preparation method thereof | |
| CN106074779A (en) | A kind of medicated wine treating burn and scald | |
| CN105902766A (en) | Peptic ulcer treating medicine and preparation method thereof | |
| CN104971157A (en) | Externally applied powder for treating beriberi and preparation method | |
| CN104161990A (en) | Traditional Chinese medicine composition for treating cardiopalmus | |
| CN102988590B (en) | Chinese medicinal composition for treating damp heat in spleen and stomach | |
| CN103705629A (en) | Traditional Chinese medicine composition for treating pruritus | |
| CN104042882A (en) | Traditional Chinese medicine preparation for treating phlegmatic nodule in eyelid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140702 |